Derek Stoldt began his practice as a corporate generalist, typically representing private equity funds and their portfolio companies in M&A, securities offerings, joint ventures and other complex contractual transactions. For the past ten years, Derek has focused his practice on representing life sciences and medical technology companies. Derek was named a “Life Sciences Star” in the 2013 edition of Euromoney’s LMG Life Sciences.
As a founding partner of the firm’s London office, Derek has substantial experience with international and cross-border transactions in Europe and South America. While in London, Derek qualified as a solicitor of the Supreme Court of England and Wales.
Derek is a frequent lecturer and is the editor of the American Bar Association’s survey of Acquisitions by Private Equity Funds of Public Companies. Derek was also the principal author of the firm’s “What’s Market” survey of private equity M&A deal terms. He has also been quoted and published in The Wall Street Journal, Buyouts, Dow Jones Newswire, The Deal, Financier Worldwide and other publications. He has served as a member of the Board of Advisors to the Corporate Counsel Institute of Georgetown University Law Center and the New York City Bar’s Committee on Mergers, Acquisitions and Contests for Corporate Control.
Derek is particularly active in continuing legal education. He established the Corporate Department’s unique “Kaye Scholer College” and conducts training programs for our lawyers and in house counsel at our clients. Derek is a member of Kaye Scholer’s Pro Bono Committee and counsels a number of community service organizations on a pro bono basis.